What adult Still disease is, in plain terms
Adult-onset Still disease is a systemic autoinflammatory condition. It is not the same as the childhood form of Still disease, and it is not simply a type of rheumatoid arthritis, although joints can be involved. The classic picture that clinicians look for includes high spiking fevers, a rash that tends to appear with the fever, joint pain or swelling, sore throat, and raised inflammatory markers in the blood. Fatigue and enlarged lymph nodes or spleen can also occur.
None of those features is unique to Still disease. Infections, lymphoma, other autoimmune diseases and several rare conditions can produce a similar pattern. That is why diagnosis is usually a process of assembling evidence and excluding mimics rather than a single blood test. A clinician may refer to classification criteria used in research, but those criteria support a diagnosis rather than replace clinical judgement.
For an overseas patient, the practical consequence is that the useful question is not "can Still disease be treated in China" in the abstract. It is whether a particular rheumatology team, seeing your particular records, can add something to the assessment and treatment plan you already have. That depends on the clarity of your history and on the team's own review.
Why the diagnosis deserves a second look before travel
Adult Still disease is uncommon, and its mimics include conditions where delay matters. Lymphoma, adult-onset infections and other systemic inflammatory diseases can present with fever, rash and high inflammatory markers. A patient labelled with Still disease who has an incomplete work-up may still need questions answered about what was excluded and how.
This is the strongest reason to treat a records review as valuable in itself. A rheumatologist reading a well-organised file can point out missing information, question whether the diagnosis fits, and suggest what the treating team at home should check. Sometimes the answer is that the current plan is reasonable and no trip is needed. That is a useful outcome, not a failed enquiry.
It also means you should be cautious about any service that offers to confirm the diagnosis remotely or to start treatment before you are seen. Diagnosis and treatment decisions belong to licensed clinicians who can examine you and review primary records, and even then a records-based opinion has limits. Ask what the reviewing team can and cannot conclude from the documents you send.
The records a rheumatology team will actually use
A Still disease review lives or dies on the quality of the history. Rather than sending everything you have, build a short chronological summary and attach the key source documents. The summary should state when symptoms began, how the fevers behave, what the rash looks like and when it appears, which joints are affected, and what has changed over time.
Blood results matter, but trends matter more than single values. Include inflammatory markers, full blood counts, liver tests and ferritin where available, with dates, so a reviewer can see the pattern rather than one snapshot. If imaging, bone marrow examination, lymph node biopsy or other tests were done to exclude alternatives, include the reports. A medication list with doses, dates started and stopped, and the reason for each change is essential, because treatment history shapes what a team would consider next.
Ask the receiving team what format and language it accepts, and whether translated summaries are useful or whether original reports are preferred. Do not send a complete archive in a first message. A brief summary with your main question is enough to start, and the team can then tell you what else it needs.
- A dated symptom timeline, including fever pattern and rash behaviour
- Inflammatory markers, blood counts, liver tests and ferritin with dates
- Reports of tests done to exclude infection, lymphoma and other mimics
- Current and previous medicines with doses and reasons for changes
- Your specific question, such as whether the diagnosis fits or what to try next
What treatment planning involves, and what you must confirm
Treatment for adult Still disease is individualised. Clinicians generally aim to control inflammation, protect joints and organs, and reduce reliance on steroids where possible, using medicines that may include corticosteroids and other immunosuppressive or biologic agents depending on the pattern and severity. Which option suits a patient depends on organ involvement, pregnancy plans, infection risk, prior response and local availability.
This is where overseas patients need to ask careful questions rather than assume. Availability of a particular medicine in China, the rules for prescribing it to a foreign patient, monitoring requirements and what happens if a course must be interrupted are all matters for the treating hospital and pharmacy, not for a coordinator. Ask the department directly which treatments it can offer to an international patient and what monitoring it requires.
Also ask how continuity would work. If you start or change treatment in China, you need a written plan that your clinician at home can follow, including what to monitor and when. Do not stop or alter medicines on your own in preparation for a trip; that decision belongs to your prescribing clinician.
How a China review could fit into your care
Some patients want a records-based opinion before deciding whether to travel. Others want an in-person rheumatology consultation, and some are seeking access to a treatment approach they cannot obtain locally. These are different requests and lead to different preparations.
A records-based opinion can be arranged while you remain at home, and it is optional rather than a prerequisite for an appointment. It is most useful when your diagnosis is uncertain, when treatment is not controlling the disease, or when you want an independent view of the plan. An in-person visit makes more sense when examination, local testing or a treatment decision that requires the patient present is the goal.
For complex cases involving several organ systems, a review drawing on more than one specialty may be appropriate, with the scope agreed in advance. Whatever route you consider, the hospital decides whether it will accept the case, and no enquiry or review establishes that treatment will be offered.
Practical questions to put to the treating team
Write your questions down before contact, because a rare-disease consultation can move quickly. Ask whether the team has experience with adult Still disease specifically, and what it would need to form a view. Ask what the consultation covers, whether an interpreter is available, and how findings and recommendations would be communicated to you and to your doctor at home.
Ask what the team can conclude from records alone and what would require you to be present. Ask which tests it would want and whether any can be done before travel. If treatment is discussed, ask about monitoring, follow-up and how a plan would be handed back to your local clinician. Ask for the written scope of any coordination service separately from hospital charges, so you can see what each part covers.
Finally, ask what would make the team advise against travelling. A patient with active fever, worsening symptoms or uncertainty about infection may be better assessed locally first. That is a clinical judgement, and it should come from a clinician who knows your case.
A sensible next step
Start with a short summary of your diagnosis, main symptoms, treatments tried and the one question you most want answered. An initial enquiry is free and does not commit you to buying a proxy consultation or travelling. Our team can check whether the records you have match what a rheumatology department would need and suggest the relevant next step, while the hospital and its clinicians decide on suitability and care.
If you are unwell now, seek local medical assessment rather than waiting on an overseas enquiry. For planning, you can begin through the care review route on this site or by email, and share fuller records only after the first contact clarifies what is needed.
Sources & scope of this guide
References and official service information relevant to this guide.
This is general planning information and has not been individually reviewed by a doctor. Medical decisions and personal treatment advice come from your treating clinicians.
